Current Therapeutic Options for Cardiovascular Diseases: From Bench to Bedside
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 5402
Special Issue Editor
Interests: platelets; coagulation; clinical trials; vascular disease; antiplatelet agents; anticoagulants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The area of vascular pharmacology is on the move and is rapidly evolving. New knowledge, however, suggests that sometimes data generated in clinical trials contradict real-life clinical scenarios. Numerous researchers and practitioners have discussed the clinical features of various cardiac diseases and optimal therapeutic options. In general, they have agreed that many patients require an individual approach to yield better outcomes. Furthermore, major outcomes may be different because of ethnicity, drug doses, and regiments challenging uniformed therapeutic recommendations. In summary, this Special Issue will focus on various approaches to national pharmaceutical management in vascular diseases, diabetes, stroke, and arrhythmias. We are expecting healthy friendly dialog debating these critical issues among top research groups.
Dr. Victor Serebruany
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiplatelet therapy
- anticoagulants
- vascular disease
- diabetes, stroke
- arrhythmia
- pharmacology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.